NCT07816614

Brief Summary

This study aims to determine the effect of mandala coloring on the quality of life in cancer patients. Conducting a quasi-experimental design with a pretest-posttest control group, the study will involve a total of 76 cancer patients hospitalized in an oncology ward. Participants will be assigned to either the experimental (mandala) group or the control group. At the baseline, data will be collected face-to-face using a Patient Information Form and the EORTC QLQ-C30 Version 3.0 Quality of Life Scale. Patients in the experimental group will be provided with a mandala coloring book and colored pencils, and they will practice mandala coloring for 30 minutes, at least twice a week, over a 3-week period. The control group will receive routine clinical care with no intervention. After 3 weeks, the EORTC QLQ-C30 scale will be re-administered to both groups to evaluate and compare changes in their quality of life.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P25-P50 for not_applicable cancer

Timeline
10mo left

Started Oct 2026

Shorter than P25 for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
Oct 2026Aug 2027

First Submitted

Initial submission to the registry

September 8, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 11, 2026

Completed
20 days until next milestone

Study Start

First participant enrolled

October 1, 2026

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2027

Last Updated

September 15, 2026

Status Verified

September 1, 2026

Enrollment Period

9 months

First QC Date

September 8, 2026

Last Update Submit

September 11, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Quality of Life Score via EORTC QLQ-C30

    Quality of life will be evaluated using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) Version 3.0. The questionnaire includes 30 items. All raw scores are linearly transformed into a standard scale ranging from 0 to 100. For the global health and functional scales, a higher score indicates a better quality of life. For the symptom scales, a higher score indicates a worse outcome.

    Baseline and 3 weeks

Study Arms (2)

Mandala Coloring Intervention

EXPERIMENTAL

Patients in this group will be provided with a mandala coloring book and 12 colored pencils. They will practice mandala coloring for 30 minutes, at least twice a week, over a 3-week period in addition to routine clinical care.

Behavioral: Mandala Coloring

Standard Care

NO INTERVENTION

Patients in this group will receive only routine clinical care during the 3-week study period and will not perform any mandala coloring activity.

Interventions

Patients in the experimental group will be provided with a mandala coloring book and a set of 12 colored pencils. They will be requested to practice mandala coloring in a quiet, distraction-free environment for 30 minutes, at least twice a week, for a total duration of 3 weeks. The intervention will be conducted in addition to routine clinical care.

Also known as: Experimental Group
Mandala Coloring Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with cancer
  • Aged 18 years and older
  • Voluntarily willing to participate in the study
  • Able to hold and use a pencil for coloring

You may not qualify if:

  • Refusing to participate or withdraws consent before the study begins
  • Unable to comply regularly with the scheduled mandala coloring program
  • Incapable of using a pencil due to physical or cognitive impairments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aydın Adnan Menderes University Hospital

Aydin, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Neoplasms

Central Study Contacts

Emine Tarlabelen Karaytug, Research Assistant, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Research Assistant, PhD

Study Record Dates

First Submitted

September 8, 2026

First Posted

September 11, 2026

Study Start

October 1, 2026

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

August 1, 2027

Last Updated

September 15, 2026

Record last verified: 2026-09

Locations